secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2022-12-08T23:59:59+00:00
Accession:  0000950170-22-026239
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia creates Series A Preferred with voting rights on reverse stock split; quorum lowered to one-third
--------------------------------------------------------------------------------

- Declared dividend of 1/1000th share of Series A Preferred per common share; record date Dec 28, 2022, distribution Dec 29, 2022.
- Each 1/1000th of Series A Preferred carries 1,000 votes, but only on proposals for a reverse stock split and adjournment.
- Preferred shares are not transferable except with transfer of common shares; voting automatically mirrors common share vote.
- Bylaws amended to reduce stockholder meeting quorum from majority to one-third of voting power.
- Unredeemed preferred shares redeemed after meeting for $0.10 per 100 shares (subject to conditions); odd lots may receive no cash.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017022026239/0000950170-22-026239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017022026239/rkda-20221207.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-026239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer